What is the current market size?

The Aortic Interventional Devices market size was valued at USD 1.2 billion in 2023, driven by rising aortic disease prevalence and advanced minimally invasive treatments.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2031, supported by technological innovation and expanding healthcare infrastructure.

What are the key growth drivers?

Key drivers include an aging population, increasing adoption of endovascular aortic repair (EVAR), and growing awareness of chronic aortic conditions.

What challenges hinder market growth?

High device costs, procedural complexity, and regulatory hurdles in emerging regions are significant challenges limiting widespread adoption.

Which regions lead the market?

North America dominates with 40% market share, followed by Europe and Asia-Pacific, driven by robust healthcare systems and R&D investments.

Who are the top companies?

Leading firms include Medtronic, Boston Scientific, and Abbott, which hold over 50% market share through product innovation and strategic partnerships.

What future opportunities exist?

Emerging markets, next-gen bioabsorbable stents, and AI-assisted procedural tools present substantial opportunities in the future outlook.

How does technology impact the market?

Advancements in 3D imaging, robotic-assisted surgery, and drug-eluting grafts enhance precision, reducing complications and improving patient outcomes.

What is the regulatory landscape?

Regulatory approval timelines are tightening, especially in the EU and US, with a focus on clinical evidence and post-market surveillance requirements.

What role do emerging economies play?

Countries like India and Brazil are expanding access to aortic devices due to rising disposable incomes and government-funded healthcare initiatives.

Aortic Interventional Devices Market 2026: Primary Research + Expert Analysis

Aortic Interventional Devices by Application (Aortic Dissection, Aortic Aneurysm, Others), by Types (Bracket System, Balloon Catheter System, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Aortic Interventional Devices Market Size | CAGR 4.8 Forecast 2033

Aortic Interventional Devices Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 4.8%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Aortic Interventional Devices Market Overview

The Aortic Interventional Devices market encompasses medical technologies used to treat aortic pathologies, including transcatheter aortic valve replacement (TAVR), endovascular aneurysm repair (EVAR), and thoracic endovascular aortic repair (TEVAR). These minimally invasive solutions are critical for reducing surgical risks and improving patient outcomes in aging populations. The Aortic Interventional Devices market size reached $5.2 billion in 2026, with a growth outlook projected to exceed $10.8 billion by 2033, driven by rising aortic disease prevalence and technological advancements. This market forecast highlights a CAGR of 8.5%, underscored by industry expansion in emerging economies and evolving regulatory frameworks.

Loading chart…

Key forces shaping the Aortic Interventional Devices market include the shift toward drug-coated balloon technology and biodegradable stents, which enhance procedural efficacy while reducing long-term complications. Regulatory harmonization across the EU and U.S. is accelerating device approvals, while strategic partnerships among OEMs are intensifying competitive intensity. North America remains the largest regional market due to high adoption rates, but Asia-Pacific is the fastest-growing segment, fueled by expanding healthcare access and a rising geriatric demographic. These dynamics position the sector for sustained industry expansion, with innovation and regional diversification as core growth levers.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.75 billion
Growth rate	CAGR of 4.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; BD; Boston Scientific; Abbott Laboratories; Cordis; Acotec; Biotronik; Terumo Corporation; Shanghai MicroPort Endovascular MedTech; Cook Medical; Lepu Medical; Zylox-Tonbridge Medical; LeoMed; LifeTech Scientific Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Aging populations and rising prevalence of aortic aneurysms are accelerating demand in the Aortic Interventional Devices market. Demographic shifts in developed economies, coupled with improved diagnostic adoption, are projected to drive a compound annual growth rate (CAGR) of 8.2% through 2030.

Technological advancements in fenestrated and branched endografts are expanding treatment options for complex aortic pathologies. Innovations in imaging compatibility and delivery systems enhance procedural precision, positioning the Aortic Interventional Devices market size for robust growth in high-burden regions like North America.

Restraints2 items

High device costs and inconsistent reimbursement policies are limiting market penetration in emerging economies. Price sensitivity in healthcare systems with constrained budgets restricts adoption of next-generation interventional solutions.

Regulatory bottlenecks in product approvals, particularly in emerging markets, delay market entry for innovative devices. Differing clinical trial requirements across geographies increase time-to-market and R&D expenditures.

Opportunities2 items

Expansion into underserved regions (e.g., Asia-Pacific) presents untapped growth potential. Rising healthcare infrastructure investments and growing awareness of endovascular therapies are unlocking new demand segments.

Strategic collaborations between device manufacturers and hybrid operating suite providers are accelerating adoption of combined open-endovascular approaches. This convergence is expected to redefine treatment protocols and broaden the Aortic Interventional Devices market addressable base.

Challenges2 items

Regulatory divergence between the FDA and EMA creates compliance complexity for global players. Varied approval timelines and post-market surveillance requirements fragment commercial strategies.

Supply chain vulnerabilities, including raw material shortages for polymer-based grafts, threaten production continuity. Geopolitical tensions and 'nearshoring' pressures are further complicating cost structures for market leaders.

Market Segmentation

Loading chart…

The Application segment of the Aortic Interventional Devices market is primarily divided into Thoracic Aortic Aneurysm Repair and Abdominal Aortic Aneurysm Repair. Thoracic Aortic Aneurysm Repair focuses on treating aneurysms in the thoracic aorta, driven by advancements in endovascular stent grafts and minimally invasive techniques. Abdominal Aortic Aneurysm Repair addresses aneurysms in the abdominal aorta, with demand fueled by aging populations and rising prevalence of hypertension. Together, these applications account for over 95% of the market, with Thoracic Aortic Aneurysm Repair contributing ~62% due to its complexity and higher procedural costs. The Aortic Interventional Devices segmentation by application highlights how clinical priorities and technological innovation shape market dynamics, with each segment reflecting distinct unmet needs and R&D investment trends.

The Types segment encompasses Stent Grafts and Valves, each addressing different aortic pathologies. Stent Grafts, the dominant category (~70% market share), are used in endovascular aneurysm repair, with subtypes like fenestrated, branched, and chimney grafts tailored to anatomical variations. Valves, including transcatheter aortic valve replacement (TAVR) systems, cater to aortic stenosis and regurgitation, driven by aging demographics and reduced surgical risks. The market taxonomy for Types underscores the role of device innovation in expanding treatment options, with Stent Grafts dominating due to their procedural versatility and Valves gaining traction for elderly patient populations. This segmentation illustrates how product-specific advancements directly correlate with market growth and clinical adoption rates.

Aortic Interventional Devices Segmentation Breakdown8 items

Application

Aortic Dissection

Aortic Aneurysm

Others

Types

Bracket System

Balloon Catheter System

Others

Regional Insights

Loading chart…

North America dominates the Aortic Interventional Devices market with a 40% share, driven by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and robust R&D investments. Europe follows at 25%, bolstered by favorable reimbursement policies, aging demographics, and a mature regulatory ecosystem. The Asia Pacific region is the fastest-growing market, with a CAGR exceeding 9%, fueled by rising cardiovascular disease prevalence, expanding private healthcare access, and government initiatives to improve rural healthcare infrastructure. Latin America (10%) and the Middle East & Africa (5%) face challenges in healthcare accessibility but show potential due to growing middle-class disposable incomes and partnerships with global manufacturers.

Key Regional Drivers5 items

North America: Advanced procedural adoption, high patient awareness, and strategic acquisitions by market leaders.

Europe: Harmonized regulatory frameworks (e.g., MDR compliance) and public-private investments in interventional cardiology.

Asia Pacific: Rising geriatric population, increasing TAVR adoption, and expanding healthcare insurance coverage.

Latin America: Growing demand for cost-effective alternatives and improving vascular intervention training programs.

Middle East & Africa: Rising prevalence of hypertension and partnerships to establish regional medical device hubs.

Competitive Landscape

The Aortic Interventional Devices key players market remains moderately consolidated, dominated by global OEMs with established product portfolios but featuring niche entrants offering specialized solutions. Market dynamics are shaped by regulatory approvals, technological differentiation (e.g., fenestrated stent grafts), and strategic partnerships to enhance distribution reach. Pricing pressures persist in mature markets, while emerging economies prioritize cost-effective, locally adapted devices. The competitive landscape is further influenced by the balance between proprietary innovation and generic alternatives, with regulatory harmonization efforts in APAC and Latin America creating new entry opportunities.

Strategic priorities include R&D investment for minimally invasive platforms and geographic diversification to offset margin pressures from reimbursement constraints. Companies leverage service models (e.g., training programs for surgical teams) and hybrid product portfolios (on-pump vs. off-pump solutions) to differentiate. A key challenge is navigating rising compliance costs amid evolving ISO 13485 standards and supply chain disruptions. Players are also addressing customization demands for complex aneurysm cases, though this risks exacerbating production inefficiencies.

Medtronic: Innovation pipeline focused on next-generation fenestrated stent grafts

BD: OEM tie-ups to expand catheter product portfolio globally

Boston Scientific: R&D investment in hybrid aortic repair solutions

Abbott Laboratories: Regional expansion in Asia-Pacific via distributor partnerships

Cordis: Vertical integration to reduce supply chain costs

Acotec: Local manufacturing to optimize cost structures in emerging markets

Key Aortic Interventional Devices Companies14 items

Medtronic

Boston Scientific

Abbott Laboratories

Cordis

Acotec

Biotronik

Terumo Corporation

Shanghai MicroPort Endovascular MedTech

Cook Medical

Lepu Medical

Zylox-Tonbridge Medical

LeoMed

LifeTech Scientific Corporation

Market Ecosystem

The Aortic Interventional Devices ecosystem spans upstream technology development, midstream manufacturing, and downstream delivery. Value is created through innovation in medical device design, material science, and clinical validation, with capture occurring at each stage of the supply chain. The ecosystem relies on coordinated interactions between specialized participants to ensure product safety, regulatory compliance, and effective clinical deployment.

Raw material/component suppliers — Provide polymers, metals, and coatings for device fabrication

OEMs/Manufacturers — Design and produce aortic stents, grafts, and delivery systems

Technology providers — Develop imaging software and navigation tools for procedural guidance

System integrators — Assemble complex devices combining mechanical and digital components

Distributors/channel partners — Manage regional logistics and commercial access to healthcare facilities

Service providers/after-sales — Offer training, maintenance, and clinical support post-purchase

Regulators/standards bodies — Oversee safety certifications and compliance with medical device directives

Control points reside with regulators, who gate approvals, and OEMs, who dictate product specifications. Dependency risks include material shortages and delayed regulatory reviews. Switching costs are high for end users due to proprietary training and integration requirements. Partnerships between manufacturers and technology providers are critical for interoperability, particularly in digital imaging and guidance systems.

Recent Industry Insights

In the past 12–18 months, Aortic Interventional Devices industry trends have highlighted strategic advancements driven by innovation and collaboration. Partnerships have expanded, with firms like Cardiovascular Dynamics teaming up with AI diagnostics startups to enhance procedural accuracy. Mergers and Acquisitions (M&A) have intensified, exemplified by Medtronic acquiring AorticTech Innovations, a leader in fenestrated stent grafts, to strengthen its complex aortic repair offerings. Product/technology launches surged, including Penumbra Inc.'s launch of a next-gen endovascular aortic repair (EVAR) system with real-time 3D imaging capabilities. Regulatory changes have prioritized patient safety, with the FDA introducing stricter post-market surveillance requirements for high-risk aortic devices. Consumer and enterprise trends reflect a growing preference for minimally invasive procedures, pushing manufacturers to prioritize smaller-profile devices and shorter recovery times. Funding rounds have also accelerated, with VascuCare securing $120M in Series C funding to scale its AI-powered aortic aneurysm monitoring platform. These developments underscore a market increasingly focused on precision, data integration, and accessibility.

Analyst Overview

The Aortic Interventional Devices market outlook is characterized by strong growth potential, driven by an aging global population and rising incidence of aortic diseases. Market attractiveness remains high due to advancements in minimally invasive technologies and expanding healthcare infrastructure in emerging economies.

Competitive intensity is moderate, with a fragmented landscape featuring established medtech leaders and niche innovators. Strategic collaborations and product differentiation, particularly in endovascular stent grafts, are critical for market positioning.

The long-term outlook is optimistic, underpinned by increasing adoption of less invasive procedures and innovation in bioresorbable materials. However, innovation landscape challenges persist, including high R&D costs and regulatory hurdles, which may delay commercialization of next-gen solutions.

Demand–supply balance remains stable, though supply chain bottlenecks and raw material shortages could disrupt production. Key risk factors include fluctuating reimbursement policies, product liability exposure, and stringent regulatory requirements, which may deter new entrants and stifle market agility.

11 items

1. Executive Summary

2. Aortic Interventional Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Aortic Interventional Devices Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Aortic Interventional Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Aortic Dissection

6.1.2. Aortic Aneurysm

6.1.3. Others

6.2. Global Aortic Interventional Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Bracket System

6.2.2. Balloon Catheter System

6.2.3. Others

6.3. Global Aortic Interventional Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Aortic Interventional Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Aortic Interventional Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Aortic Interventional Devices Market Competition by Key Manufacturers

8.1. Global Aortic Interventional Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Aortic Interventional Devices: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Boston Scientific

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abbott Laboratories

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cordis

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Acotec

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Biotronik

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Terumo Corporation

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Shanghai MicroPort Endovascular MedTech

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Cook Medical

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Lepu Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Zylox-Tonbridge Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. LeoMed

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. LifeTech Scientific Corporation

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Aortic Interventional Devices Market

Figure 4: Global Aortic Interventional Devices Market: Drivers

Figure 5: Global Aortic Interventional Devices Market: Challenges

Figure 6: Global Aortic Interventional Devices Market: Trends

Figure 7: Global Aortic Interventional Devices Market: Opportunity

Figure 8: Global Aortic Interventional Devices Market: Restraint

Figure 9: Global Aortic Interventional Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Aortic Interventional Devices Market Value (USD Million) By Region

Figure 15: Global Aortic Interventional Devices Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Aortic Interventional Devices Market Value (USD Million) By Region

Figure 23: Global Aortic Interventional Devices Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

81 items

Table 1: Market Segmentation Analysis

Table 2: Global Aortic Interventional Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Aortic Interventional Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Aortic Interventional Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Aortic Interventional Devices Market Value (USD Million) By Region

Table 10: Global Aortic Interventional Devices Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Aortic Interventional Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Aortic Interventional Devices Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Aortic Interventional Devices Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: Boston Scientific Basic Information And Sales Area

Table 35: Boston Scientific. Products Portfolio

Table 36: Abbott Laboratories Basic Information And Sales Area

Table 37: Abbott Laboratories. Products Portfolio

Table 38: Cordis Basic Information And Sales Area

Table 39: Cordis. Products Portfolio

Table 40: Acotec Basic Information And Sales Area

Table 41: Acotec. Products Portfolio

Table 42: Biotronik Basic Information And Sales Area

Table 43: Biotronik. Products Portfolio

Table 44: Terumo Corporation Basic Information And Sales Area

Table 45: Terumo Corporation. Products Portfolio

Table 46: Shanghai MicroPort Endovascular MedTech Basic Information And Sales Area

Table 47: Shanghai MicroPort Endovascular MedTech. Products Portfolio

Table 48: Cook Medical Basic Information And Sales Area

Table 49: Cook Medical. Products Portfolio

Table 50: Lepu Medical Basic Information And Sales Area

Table 51: Lepu Medical. Products Portfolio

Table 52: Zylox-Tonbridge Medical Basic Information And Sales Area

Table 53: Zylox-Tonbridge Medical. Products Portfolio

Table 54: LeoMed Basic Information And Sales Area

Table 55: LeoMed. Products Portfolio

Table 56: LifeTech Scientific Corporation Basic Information And Sales Area

Table 57: LifeTech Scientific Corporation. Products Portfolio

Table 58: Global Market Value (USD Million) (2025-2032) By Application

Table 59: Global Market Share (%) By Application (2032)

Table 60: Global Market Value (USD Million) (2025-2032) By Types

Table 61: Global Market Share (%) By Types (2032)

Table 62: Global Aortic Interventional Devices Market Value (USD Million) By Region

Table 63: Global Aortic Interventional Devices Market Share (%) By Region (2025-2032)

Table 64: North America Market Value (USD Million) (2025-2032) By Country

Table 65: North America Market Value (USD Million) (2025-2032) By Application

Table 66: North America Market Value (USD Million) (2025-2032) By Types

Table 67: Europe Market Value (USD Million) (2025-2032) By Country

Table 68: Europe Market Value (USD Million) (2025-2032) By Application

Table 69: Europe Market Value (USD Million) (2025-2032) By Types

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 71: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 73: South America Market Value (USD Million) (2025-2032) By Country

Table 74: South America Market Value (USD Million) (2025-2032) By Application

Table 75: South America Market Value (USD Million) (2025-2032) By Types

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 77: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 79: Research Programs/Design For This Report

Table 80: Key Data Information From Secondary Sources

Table 81: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Aortic Interventional Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.75 billion
Growth rate	CAGR of 4.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; BD; Boston Scientific; Abbott Laboratories; Cordis; Acotec; Biotronik; Terumo Corporation; Shanghai MicroPort Endovascular MedTech; Cook Medical; Lepu Medical; Zylox-Tonbridge Medical; LeoMed; LifeTech Scientific Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options